Status:
TERMINATED
Efficacy of Nuts in Obese Children.
Lead Sponsor:
Universita di Verona
Conditions:
Child Obesity
Eligibility:
All Genders
6-17 years
Phase:
NA
Brief Summary
Obesity is a problem of ever-growing importance, especially in industrialized countries, both in adults and in the pediatric population. Children and obese adolescents, like adults, have an increased ...
Detailed Description
Obesity is a problem of ever-growing importance, especially in industrialized countries, widespread both in adults and in the pediatric population. Children and obese adolescents, like adults, have a...
Eligibility Criteria
Inclusion
- obese subjects (BMI ≥ 95th percentile for age and sex; reference tables for WHO BMI);
- Aged between 6 and 17 years;
- Signature applied in the informed consent by both parents and consent of the child
Exclusion
- chronic liver diseases (hepatitis, cirrhosis).
- Chronic renal failure (serum creatinine\> 1.2 mg / dL).
- Malignancies.
- Diabetes (fasting blood glucose ≥ 126 mg / dl or therapy with oral hypoglycemic drugs or insulin).
- cholesterol-lowering or antihypertensive terapy.
- Notes allergies to nuts or hazelnuts or food intolerance to nuts and/or hazelnuts.
- Treatment of less than 6 weeks with any medication which can interfere with fecal microbiota (particularly antibiotics or laxatives).
Key Trial Info
Start Date :
March 19 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 18 2022
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT03870984
Start Date
March 19 2019
End Date
May 18 2022
Last Update
May 25 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
AOUI Verona
Verona, VR, Italy, 37134